UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000020242
Receipt No. R000023226
Scientific Title A phase III study comparing gefitinib and inserted cisplatin and pemetrexed with gefitinib as a first-line treatment for patients with advanced non-squamous non-small-cell lung cancer harboring EGFR activating mutation (JCOG1404/WJOG8214L, AGAIN study)
Date of disclosure of the study information 2015/12/17
Last modified on 2016/06/23 18:10:35

No. Disposal Last modified on Item of update
1 Insert 2015/12/17 10:49:26
2 Update 2016/06/23 18:10:35 Last name of lead principal investigator
Last name of lead principal investigator
Email
Name of primary sponsor
Organization
Organization
Organization
Institutions


Contact us.